Cargando…
尼洛替尼暴露对女性慢性髓性白血病患者妊娠结局的影响
OBJECTIVE: To observe the pregnancy outcome among patients with chronic myeloid leukemia(CML)treated with Nilotinib(NIL). METHODS: Clinical data of pregnancy delivery in CML patients treated with NIL from March 2015 to January 2019 were retrospectively collected. RESULTS: A total of 11 patients were...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342686/ https://www.ncbi.nlm.nih.gov/pubmed/32023727 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2019.12.003 |
Ejemplares similares
-
尼洛替尼与伊马替尼一线治疗初发慢性髓性白血病患者的比较研究
Publicado: (2019) -
伊马替尼对慢性髓性白血病慢性期儿童身高的影响
Publicado: (2020) -
尼洛替尼和达沙替尼作为二三线药物治疗慢性髓性白血病慢性期和加速期患者的疗效及影响因素分析
Publicado: (2020) -
尼洛替尼一线治疗慢性髓性白血病的疗效及影响实现分子学反应的因素分析
Publicado: (2020) -
原研伊马替尼或尼洛替尼转换国产伊马替尼治疗慢性髓性白血病慢性期患者有效性、安全性和生活质量研究
Publicado: (2019)